Lymphocyte-proliferative responses to HIV antigens as a potential measure of immunological reconstitution in HIV disease
- PMID: 9672234
Lymphocyte-proliferative responses to HIV antigens as a potential measure of immunological reconstitution in HIV disease
Abstract
Lymphocyte-proliferative responses (LPRs) to HIV antigens are absent or of low magnitude in the majority of HIV-infected individuals, even early in the disease. However, lymphocytes from 2% to 3% of individuals proliferate very strongly to HIV Env or Gag antigens, and these individuals remain well clinically, without antiretroviral therapy. In established HIV infection, suppression of HIV-replication with potent antiretroviral therapy does not result in the development of strong LPRs to HIV antigens. Large LPRs to HIV antigens can be induced by HIV vaccines in patients with established infection, even though they were not formed in response to infection. Studies must be designed to determine whether large LPRs induced by vaccines administered in conjunction with potent antiretroviral therapy are associated with long-term control of HIV infection.
Similar articles
-
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13878-83. doi: 10.1073/pnas.251539598. Proc Natl Acad Sci U S A. 2001. PMID: 11717444 Free PMC article.
-
Assessment of human cytomegalovirus specific T cell immunity in human immunodeficiency virus infected patients in different disease stages following HAART and in long-term non-progressors.J Med Virol. 2004 Nov;74(3):382-9. doi: 10.1002/jmv.20191. J Med Virol. 2004. PMID: 15368523
-
Proliferative responses to human immunodeficiency virus type 1 (HIV-1) antigens in HIV-1-infected patients with immune reconstitution.J Infect Dis. 2001 Feb 15;183(4):657-61. doi: 10.1086/318545. Epub 2001 Jan 12. J Infect Dis. 2001. PMID: 11170994
-
Antiretroviral therapy in 1999 for antiretroviral-naive individuals with HIV infection.AIDS. 1999 Sep;13 Suppl 1:S49-59. AIDS. 1999. PMID: 10546785 Review.
-
Molecular biological assessment methods and understanding the course of the HIV infection.APMIS Suppl. 2003;(114):1-37. APMIS Suppl. 2003. PMID: 14626050 Review.
Cited by
-
The Role of CD4(+) and CD8(+) T Cells in Controlling HIV Infection.Curr Infect Dis Rep. 2002 Oct;4(5):461-467. doi: 10.1007/s11908-002-0014-2. Curr Infect Dis Rep. 2002. PMID: 12228034
-
A phase I, randomized study of combined IL-2 and therapeutic immunisation with antiretroviral therapy.J Immune Based Ther Vaccines. 2007 Apr 11;5:6. doi: 10.1186/1476-8518-5-6. J Immune Based Ther Vaccines. 2007. PMID: 17428345 Free PMC article.
-
HIV-1 viremia prevents the establishment of interleukin 2-producing HIV-specific memory CD4+ T cells endowed with proliferative capacity.J Exp Med. 2003 Dec 15;198(12):1909-22. doi: 10.1084/jem.20031598. J Exp Med. 2003. PMID: 14676302 Free PMC article.
-
Diminished proliferation of human immunodeficiency virus-specific CD4+ T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2.J Virol. 2003 Oct;77(20):10900-9. doi: 10.1128/jvi.77.20.10900-10909.2003. J Virol. 2003. PMID: 14512540 Free PMC article.
-
High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation.Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13878-83. doi: 10.1073/pnas.251539598. Proc Natl Acad Sci U S A. 2001. PMID: 11717444 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical